1. Home
  2. LUNG vs ASG Comparison

LUNG vs ASG Comparison

Compare LUNG & ASG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LUNG
  • ASG
  • Stock Information
  • Founded
  • LUNG 1995
  • ASG 1986
  • Country
  • LUNG United States
  • ASG United States
  • Employees
  • LUNG N/A
  • ASG N/A
  • Industry
  • LUNG Industrial Specialties
  • ASG Investment Managers
  • Sector
  • LUNG Health Care
  • ASG Finance
  • Exchange
  • LUNG Nasdaq
  • ASG Nasdaq
  • Market Cap
  • LUNG 248.0M
  • ASG 312.2M
  • IPO Year
  • LUNG 2020
  • ASG N/A
  • Fundamental
  • Price
  • LUNG $7.31
  • ASG $5.30
  • Analyst Decision
  • LUNG Strong Buy
  • ASG
  • Analyst Count
  • LUNG 8
  • ASG 0
  • Target Price
  • LUNG $14.88
  • ASG N/A
  • AVG Volume (30 Days)
  • LUNG 300.6K
  • ASG 324.3K
  • Earning Date
  • LUNG 10-28-2024
  • ASG 01-01-0001
  • Dividend Yield
  • LUNG N/A
  • ASG 8.09%
  • EPS Growth
  • LUNG N/A
  • ASG N/A
  • EPS
  • LUNG N/A
  • ASG N/A
  • Revenue
  • LUNG $76,583,000.00
  • ASG N/A
  • Revenue This Year
  • LUNG $22.73
  • ASG N/A
  • Revenue Next Year
  • LUNG $19.02
  • ASG N/A
  • P/E Ratio
  • LUNG N/A
  • ASG N/A
  • Revenue Growth
  • LUNG 26.26
  • ASG N/A
  • 52 Week Low
  • LUNG $5.46
  • ASG $4.47
  • 52 Week High
  • LUNG $14.84
  • ASG $5.71
  • Technical
  • Relative Strength Index (RSI)
  • LUNG 55.79
  • ASG 45.20
  • Support Level
  • LUNG $6.31
  • ASG $5.37
  • Resistance Level
  • LUNG $7.68
  • ASG $5.47
  • Average True Range (ATR)
  • LUNG 0.46
  • ASG 0.07
  • MACD
  • LUNG 0.02
  • ASG -0.00
  • Stochastic Oscillator
  • LUNG 61.73
  • ASG 13.64

About LUNG Pulmonx Corporation

Pulmonx Corp is a commercial-stage medical technology company. It provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease (COPD). The company's solutions are comprised of the Zephyr Endobronchial Valve, the Chartis Pulmonary Assessment System and the StratX Lung Analysis Platform. It generates revenue through the sale of products to distributors and hospitals in the United States which a key revenue generating market, Europe, Middle-East and Africa, Asia Pacific and other regions.

About ASG Liberty All-Star Growth Fund Inc.

Liberty All Star Growth Fund Inc is the United States based diversified, closed-end management investment company. Its investment objective is to seek long-term capital appreciation through investment in a diversified portfolio of equity securities. The company portfolio of investments consists of different industries such as consumer discretionary, consumer staples, healthcare, industrial, information technology and others.

Share on Social Networks: